From: Novel inhibitors of the calcineurin/NFATc hub - alternatives to CsA and FK506?
Inhibitor | Mode of action | IC50/Kd*/Ki** | References |
---|---|---|---|
General protein phosphatase inhibitors inhibiting also calcineurin (CaN) | |||
Endothall | binds to the active centre of PP1, PP2A, CaN | 11,5 μM** a | Tatlock JH 1997 [195] |
FMPP | binds covalently to the active centre of PP1, PP2A, CaN | 44 mMb | Born TL 1995 [88] |
Norcantharidin | binds to the active centre of PP1, PP2A, CaN | 31 μMb | Steward SG 2007 [90] |
Okadaic acid | binds to the active centre of PP1, PP2A, CaN | 4.6 μMb | Bialojan C 1988 [196] |
Tyrphostins | bind possibly to the active centre of PP1, PP2A, CaN | 21 - 62 μMb | Martin BL 1998 [89] |
Inhibitors of calcineurin-dependent signalling - CsA, FK506 and derivatives | |||
CsA/CypA | complex blocks substrate access to the active centre of CaN | 7 nMa | Fruman DA 1992 [197] |
ISA247/CypA | complex blocks substrate access to the active centre of CaN | ~100 nMa | Aspeslet L 2001 [75] |
[Dat-Sar]3-CsA | blocks substrate access to CaN independent of CypA | 1 μMa | Baumgrass R 2004 [73] |
FK506/FKBP12 | complex blocks substrate access to the active centre of CaN | 0.4 nMa | Fruman DA 1992 [197] |
Ascomycin/FKBP12 | complex blocks substrate access to the active centre of CaN | 0.7 nMm | Sinclair PJ 1996 [198] |
Pimecrolimus/FKBP12 | complex blocks substrate access to the active centre of CaN | 0.4 nMa | Grassberger M 1999 [82] |
Inhibitors of calcineurin-dependent signalling - alternative inhibitory compounds | |||
1,5-dibenzoyloxymethyl-norcantharidin | binds to the active centre of CaN | 7 μMa | Baba Y 2003 [101] |
AM404 | inhibits NFATc-DNA binding | 10 μMc | Caballero FJ 2007 [132] |
BTP1 | inhibits of NFATc dephosphorylation in cells | 60 nMd | Trevillyan JM 2001 [118] |
BTP2 | decreases Ca2+ influx into cytosol | 10 nMc | Ishikawa J 2003 [119] |
Dibefurin | inhibits enzymatic activity of CaN | 44 μMe | Brill GM 1996 [110] |
Dipyridamole | disrupts CaN-NFATc binding | ~10 μMa | Mulero C 2009 [111] |
Gossypol | inhibits enzymatic activity of CaN | 17 μMa | Baumgrass R 2001 [199] |
INCA1 |  | 0.5 μM* f | Roehrl MH 2004 [114] |
INCA2 | disturb CaN-NFATc complex formation by covalent binding to CaN | 0.12 μM* f | Roehrl MH 2004 [114] |
INCA6 |  | 0.8 μM* f | Roehrl MH 2004 [114] |
Kaempferol | inhibits enzymatic activity of CaN | 51.3 μMa | Wang H 2008 [94] |
Lie120 | inhibits enzymatic activity of CaN | 5 μMa | Klettner A 2001 [80] |
NCI3 | disturbs CaN-NFATc binding in cells | 2 μMc | Sieber M 2007 [113] |
PD 144795 | inhibits enzymatic activity of CaN | ~3 μMa | Gualberto A 1998 [109] |
Roc-1 | enhances rephosphorylation and nuclear export of NFATc | 5~25 nMc | Proksch P 2005 [136] |
ST1959/DL111-IT | enhances nuclear export of NFATc | 13.5 μM | Lindstedt R 2009 [128] |
Thiopental | inhibits CaM-dependent activity of CaN | 0.18 mMa | Humar M 2004 [97] |
Trifluoperazine | inhibits binding of CaM to CaN | 8 μMg | Aussel C 1995 [144] |
Tropisetron | inhibits CaN-dependent NFATc transactivation | ~50 μMc | Vega Lde L 2005 [138] |
UR-1505 | inhibits NFATc binding to DNA | 100~300 μMh | Román J 2007 [133] |
WIN 53071 | alters NFATc binding to DNA | 3.4 μMh | Baine Y 1995 [141] |
Inhibitors of calcineurin-dependent signalling - unknown mode of action | |||
Caffeic Acid Phenethyl Ester | N.D. | 0,1~1 μMc | Marquez N 2003 [146] |
KRM-III | N.D. | 5 μMc | Jung EJ 2009 [145] |
NFAT-68 | N.D. | 0.63 μMc | Burres NS 1995 [152] |
YM-53792 | N.D. | 50 nMc | Kuromitsu S 1997 [149] |
Punicalagin | N.D. | < 5 μMg | Lee SI 2008 [153] |
Imperatorin | N.D. | 37 μMc | Marquez N 2004 [154] |
Quinolone alkaloid compounds 1 and 3 | N.D. | 3.4 μMc | Jin HZ 2004 [155] |
Impressic acid | N.D. | 12.6 μMc | Cai XF 2004 [159] |
oleanane triterpenoid compound 3 | N.D. | 4.6 μMc | Dat NT 2004 [162] |
Gomisin N | N.D. | 1.33 μMc | Lee IS 2003 [163] |